Literature DB >> 7535923

Mutational sensitivity patterns define critical residues in the palm subdomain of the reverse transcriptase of human immunodeficiency virus type 1.

S F Chao1, V L Chan, P Juranka, A H Kaplan, R Swanstrom, C A Hutchison.   

Abstract

We have analyzed 154 single amino acid replacement mutants within a 40 amino acid region (residues 164-203) of the reverse transcriptase (RT) from human immunodeficiency virus type 1 (HIV-1). This region consists of two antiparallel beta-strands (strands 9 and 10) flanked by two alpha helices (E and F). The structure of this region of the 'palm' subdomain is conserved in a variety of DNA and RNA polymerases, indicating a critical role in enzyme structure and function. Functional assays were performed by screening RT activity of mutants expressed in E. coli. A functionally important region corresponding closely to beta-strands 9 and 10 and the loop joining them was revealed by its mutational sensitivity. Structural analysis of mutants was performed by using Western blots to assay correct folding, which is required for processing to produce the mature p66 and p51 RT species. This analysis indicates that beta-strand 10 is a structurally important region. Combined analysis of these two assays revealed diagnostic patterns of mutational sensitivity which identify key positions in the RT sequence at which a specific amino acid side chain is critical, either for structure or function, as well as residues which are external to the RT structure. This work illustrates the utility of large-scale mutagenesis in relating primary sequence to significant features of protein structure and function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535923      PMCID: PMC306763          DOI: 10.1093/nar/23.5.803

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.

Authors:  D M Lowe; V Parmar; S D Kemp; B A Larder
Journal:  FEBS Lett       Date:  1991-05-06       Impact factor: 4.124

3.  Complete mutagenesis of protein coding domains.

Authors:  C A Hutchison; R Swanstrom; D D Loeb
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Mutational remodeling of enzyme specificity.

Authors:  R Bone; D A Agard
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

5.  An attempt to unify the structure of polymerases.

Authors:  M Delarue; O Poch; N Tordo; D Moras; P Argos
Journal:  Protein Eng       Date:  1990-05

6.  Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.

Authors:  C K Shih; J M Rose; G L Hansen; J C Wu; A Bacolla; J A Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

7.  A directed DNA sequencing strategy based upon Tn3 transposon mutagenesis: application to the ADE1 locus on Saccharomyces cerevisiae chromosome I.

Authors:  C J Davies; C A Hutchison
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

8.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

9.  Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis.

Authors:  K de Vreese; Z Debyser; A M Vandamme; R Pauwels; J Desmyter; E de Clercq; J Anné
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

10.  Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase.

Authors:  S F Le Grice; T Naas; B Wohlgensinger; O Schatz
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  19 in total

Review 1.  Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Karidia Diallo; Matthias Götte; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

2.  Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity.

Authors:  E K Halvas; E S Svarovskaia; V K Pathak
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  A mutation at position 190 of human immunodeficiency virus type 1 reverse transcriptase interacts with mutations at positions 74 and 75 via the template primer.

Authors:  P L Boyer; H Q Gao; S H Hughes
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

4.  A genetic approach for identifying critical residues in the fingers and palm subdomains of HIV-1 reverse transcriptase.

Authors:  J A Wrobel; S F Chao; M J Conrad; J D Merker; R Swanstrom; G J Pielak; C A Hutchison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

5.  The glutamine side chain at position 91 on the β5a-β5b loop of human immunodeficiency virus type 1 reverse transcriptase is required for stabilizing the dNTP binding pocket.

Authors:  Nootan Pandey; Chaturbhuj A Mishra; Dinesh Manvar; Alok K Upadhyay; Tanaji T Talele; Thomas W Comollo; Neerja Kaushik-Basu; Virendra N Pandey
Journal:  Biochemistry       Date:  2011-08-23       Impact factor: 3.162

6.  Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine.

Authors:  Sean P McBurney; Gary Landucci; Donald N Forthal; Ted M Ross
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-21       Impact factor: 2.205

7.  Analysis of mutations at position 184 in reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; S H Hughes
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

8.  Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  W Keulen; N K Back; A van Wijk; C A Boucher; B Berkhout
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

9.  Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Alok Mulky; Stefan G Sarafianos; Edward Arnold; Xiaoyun Wu; John C Kappes
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  L F Rezende; W C Drosopoulos; V R Prasad
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.